- CTIC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
CTI BioPharma (CTIC) S-3Shelf registration
Filed: 11 Feb 04, 12:00am
Exhibit 23.2
Independent Auditors’ Consent
The Board of Directors
Cell Therapeutics, Inc.:
We consent to the incorporation by reference in the Registration Statement on Form S-3 of Cell Therapeutics, Inc. and of our report dated August 6, 2003, with respect to the balance sheets of Novuspharma S.p.A., a development stage company, as of December 31, 2002 and 2001, and the related statements of operations, shareholders’ equity, and cash flows for each of the years in the three year period ended December 31, 2002 and for the period from January 1, 1999 (inception) to December 31, 2002, which report appears in the Form 8-K/A of Cell Therapeutics, Inc. dated February 5, 2004.
Milan
February 11, 2004
/s/ KPMG S.p.A.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.